Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - EuropaBio

  • GEN | Biolinks
    ... Life Sciences Epizyme Eppendorf Eppendorf North America Esperance Pharmaceuticals EuropaBio European Association of Pharma Biotechnology European Bioinformatics Institute ...
  • Personalized Medicine: Why We Are So Excited
    So... why don't we? How can anyone be opposed to such an innovation? These were the two questions the EuropaBio Personalised Medicine Taskforce tried to answer. We organised ...
    3-8-2013
  • Featured Video: How Far Biotech Has Come
    GEN brings you the best, most informative and/or entertaining biotech-related videos on the web! We know how important biotechnology is for medical and industrial purposes, but did ...
    1-3-2013
  • Hungary Bids for Prime Spot in EU Biotech
    in the new EU Member States: An emerging sector" by Venture Valuation and EuropaBio. ... council director of EuropaBio. "International companies have a strong presence here. ...
    5-1-2010
  • Report Highlights Biotech Strengths, Opportunities, and Weaknesses...
    ... In a separate Policy Recommendations document, EuropaBio and Venture Valuation pinpoint ... Willy De Greef, secretary general of EuropaBio, and Patrick Frei Ph.D., CEO at Venture ...
    12-2-2009
  • Emerging Biotechnology Clusters
    these clusters have formed because of local political interest. "Consequently, many of the clusters don't reach critical mass," notes Willy DeGreef, secretary general, EuropaBio. ...
    5-1-2009
  • New Biomanufacturing Opportunities & Challenges
    Johan Vanhemelrijck, Ph.D., secretary general of Europabio said, "We often forget to tell politicians and the authorities about all the good things biotech is doing." To this end, ...
    6-15-2005

GEN Poll

More » Poll Results » Archive »

Genome Sequencing and Patient Autonomy

Do you think ACMG’s recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy?

Suggest a Poll